![Lung Yeh Cho](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Lung Yeh Cho
Direktor/Vorstandsmitglied bei OBI PHARMA, INC.
Aktive Positionen von Lung Yeh Cho
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
OBI PHARMA, INC. | Direktor/Vorstandsmitglied | 07.02.2013 | - |
Renbio Holdings Ltd. | Direktor/Vorstandsmitglied | - | - |
Karriereverlauf von Lung Yeh Cho
Ehemalige bekannte Positionen von Lung Yeh Cho
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
KPMG Taiwan Inc.
![]() KPMG Taiwan Inc. Investment ManagersFinance KPMG Taiwan Inc. provides financial advisory services. The private company is based in Taipei, Taiwan. The Taiwanese company was founded by Kuo Feng Wu, Pao Kuei Chu. The CEO is Kwo-Juh Maa. | Corporate Officer/Principal | - | - |
Diamond BioFund Inc /Investment/
![]() Diamond BioFund Inc /Investment/ Investment ManagersFinance Diamond BioFund Inc (Diamond BioFund) is an independent venture capital firm founded in 2013 by Microbio Group, Fubon Financial, Taishin Holdings and Ruentex Group. The firm is headquartered in Taipei, Taiwan. | Direktor/Vorstandsmitglied | - | - |
RenBio, Inc.
![]() RenBio, Inc. BiotechnologyHealth Technology RenBio, Inc. is a preclinical biotechnology company based in New York, NY. The company is focused on developing novel antiviral antibody therapeutics and a next-generation antibody delivery platform. RenBio's lead compound, rb-100, is a SARS-CoV-2 bispecific antibody that has demonstrated robust antiviral activity against emerging and evolving SARS-CoV-2 variants. The company is also developing a revolutionary, next-generation nucleic acid-based antibody delivery platform called Myo (Make Your Own) Technology™. RenBio was co-founded by David D. Ho, a world-renowned HIV expert and founding scientific director of the Aaron Diamond AIDS Research Center, and Yaoxing Huang, an associate professor of medical sciences at Columbia University Vagelos College of Physicians and Surgeons. The company has received non-dilutive financing from the Defense Advanced Research Projects Agency (DARPA), the Bill and Melinda Gates Foundation, and MedImmune (now AstraZeneca). | Direktor/Vorstandsmitglied | - | - |
TAIMED BIOLOGICS INC. | Direktor/Vorstandsmitglied | 12.06.2009 | - |
TANVEX BIOPHARMA, INC. | Direktor/Vorstandsmitglied | 04.10.2013 | - |
Ausbildung von Lung Yeh Cho
National Taipei University | Undergraduate Degree |
Statistik
International
Taiwan | 7 |
Vereinigte Staaten | 2 |
Vereinigtes Königreich | 2 |
Operativ
Director/Board Member | 6 |
Undergraduate Degree | 1 |
Corporate Officer/Principal | 1 |
Sektoral
Health Technology | 5 |
Finance | 3 |
Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 3 |
---|---|
OBI PHARMA, INC. | Health Technology |
TANVEX BIOPHARMA, INC. | Health Technology |
TAIMED BIOLOGICS INC. | Health Technology |
Private Unternehmen | 4 |
---|---|
RenBio, Inc.
![]() RenBio, Inc. BiotechnologyHealth Technology RenBio, Inc. is a preclinical biotechnology company based in New York, NY. The company is focused on developing novel antiviral antibody therapeutics and a next-generation antibody delivery platform. RenBio's lead compound, rb-100, is a SARS-CoV-2 bispecific antibody that has demonstrated robust antiviral activity against emerging and evolving SARS-CoV-2 variants. The company is also developing a revolutionary, next-generation nucleic acid-based antibody delivery platform called Myo (Make Your Own) Technology™. RenBio was co-founded by David D. Ho, a world-renowned HIV expert and founding scientific director of the Aaron Diamond AIDS Research Center, and Yaoxing Huang, an associate professor of medical sciences at Columbia University Vagelos College of Physicians and Surgeons. The company has received non-dilutive financing from the Defense Advanced Research Projects Agency (DARPA), the Bill and Melinda Gates Foundation, and MedImmune (now AstraZeneca). | Health Technology |
Renbio Holdings Ltd. | |
Diamond BioFund Inc /Investment/
![]() Diamond BioFund Inc /Investment/ Investment ManagersFinance Diamond BioFund Inc (Diamond BioFund) is an independent venture capital firm founded in 2013 by Microbio Group, Fubon Financial, Taishin Holdings and Ruentex Group. The firm is headquartered in Taipei, Taiwan. | Finance |
KPMG Taiwan Inc.
![]() KPMG Taiwan Inc. Investment ManagersFinance KPMG Taiwan Inc. provides financial advisory services. The private company is based in Taipei, Taiwan. The Taiwanese company was founded by Kuo Feng Wu, Pao Kuei Chu. The CEO is Kwo-Juh Maa. | Finance |
- Börse
- Insiders
- Lung Yeh Cho
- Erfahrung